0001493152-26-019027.txt : 20260427 0001493152-26-019027.hdr.sgml : 20260427 20260427062444 ACCESSION NUMBER: 0001493152-26-019027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260421 FILED AS OF DATE: 20260427 DATE AS OF CHANGE: 20260427 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stetz Gary S. CENTRAL INDEX KEY: 0001532793 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36856 FILM NUMBER: 26896420 MAIL ADDRESS: STREET 1: 104-110 AVENUE C CITY: BAYONNE STATE: NJ ZIP: 07002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Hepion Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001583771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 462783806 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 34 SHREWSBURY AVE. STREET 2: SUITE 1D CITY: RED BANK STATE: NJ ZIP: 07701 BUSINESS PHONE: 732-902-4000 MAIL ADDRESS: STREET 1: 34 SHREWSBURY AVE. STREET 2: SUITE 1D CITY: RED BANK STATE: NJ ZIP: 07701 FORMER COMPANY: FORMER CONFORMED NAME: ContraVir Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20130806 4 1 ownership.xml 4 X0609 4 2026-04-21 0 0001583771 Hepion Pharmaceuticals, Inc. HEPA 0001532793 Stetz Gary S. false C/O HEPION PHARMACEUTICALS, INC. 34 SHREWSBURY AVE., SUITE 1D RED BANK NJ 07701 1 1 0 0 Interim CEO 0 Common Stock, par value $0.0001 per share 2026-04-21 4 P 0 1250000 0.04 A 1250000 I See Footnote Through Stetz Belgiovine CPA 401K F/B/O Gary S. Stetz /s/ Gary S. Stetz 2026-04-27